Global pharmaceutical companies are setting up Global Capability Centers (GCCs) in India in an effort to promote digital transformation. By taking advantage of the abundance of IT expertise in the nation, corporations such as Novo Nordisk, Eli Lilly, Sanofi, and Takeda have increased their presence.
Industry participants say that two of the main reasons why businesses are looking to India during a downturn in the economy are political stability and strong local demand.
An Ernst & Young analysis estimates that there would be more than $100 billion in Global Capability Centers in India, with 2,500 centers and more than 4.5 million professionals working there. The tech-based GCCs are not the only ones experiencing this growth. According to a Healthark whitepaper, the number of GCCs in the Life Sciences and Healthcare (LSHC) category is predicted to rise from 100 in 2024 to over 160 by 2030, employing over 4,20,000 experts.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
